We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.59B
AUM Growth
+$296M
Cap. Flow
+$232M
Cap. Flow %
14.57%
Top 10 Hldgs %
33.37%
Holding
457
New
156
Increased
101
Reduced
125
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 13.33%
2 Financials 7.27%
3 Healthcare 6.38%
4 Industrials 5.51%
5 Communication Services 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGF icon
126
iShares Global Infrastructure ETF
IGF
$11B
$3.01M 0.19%
66,660
CMI icon
127
Cummins
CMI
$91.2B
$3M 0.19%
16,998
-600
-3% -$103K
NVDA icon
128
NVIDIA
NVDA
$5.14T
$3M 0.19%
+620,120
New +$3.08M
MAN icon
129
ManpowerGroup
MAN
$2.4B
$2.92M 0.18%
+23,153
New +$2.89M
GBT
130
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.86M 0.18%
72,700
+27,000
+59% +$1.01M
VZ icon
131
Verizon
VZ
$185B
$2.86M 0.18%
54,021
-2,829
-5% -$139K
ONCE
132
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.84M 0.18%
55,155
+14,555
+36% +$1.05M
CTSH icon
133
Cognizant
CTSH
$20.4B
$2.83M 0.18%
+39,915
New +$2.92M
VPU
134
Vanguard Utilities ETF
VPU
$8.78B
$2.83M 0.18%
24,274
-465
-2% -$56.2K
ORBK
135
DELISTED
Orbotech Ltd
ORBK
$2.78M 0.18%
+55,400
New +$2.7M
WVE icon
136
Wave Life Sciences
WVE
$1.1B
$2.77M 0.17%
+79,000
New +$2.3M
BAH icon
137
Booz Allen Hamilton
BAH
$7.93B
$2.76M 0.17%
+72,400
New +$2.74M
ARNA
138
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.75M 0.17%
+81,000
New +$2.31M
PX
139
DELISTED
Praxair Inc
PX
$2.75M 0.17%
17,785
-582
-3% -$86.3K
GILD icon
140
Gilead Sciences
GILD
$162B
$2.73M 0.17%
38,082
-6,694
-15% -$508K
XOM icon
141
ExxonMobil
XOM
$640B
$2.71M 0.17%
32,347
-180
-0.6% -$14.9K
VDE icon
142
Vanguard Energy ETF
VDE
$10B
$2.71M 0.17%
27,335
-2,455
-8% -$231K
INTU icon
143
Intuit
INTU
$77.8B
$2.69M 0.17%
17,066
+14,695
+620% +$2.24M
AVGO icon
144
Broadcom
AVGO
$1.89T
$2.69M 0.17%
+104,770
New +$2.72M
TMO icon
145
Thermo Fisher Scientific
TMO
$196B
$2.66M 0.17%
14,015
-17,968
-56% -$3.44M
EEFT icon
146
Euronet Worldwide
EEFT
$2.97B
$2.61M 0.16%
+31,000
New +$2.87M
FTV icon
147
Fortive
FTV
$18.4B
$2.59M 0.16%
56,801
-6,809
-11% -$312K
HUBS icon
148
HubSpot
HUBS
$10.5B
$2.48M 0.16%
+28,000
New +$2.35M
PRGS icon
149
Progress Software
PRGS
$1.55B
$2.47M 0.16%
+58,100
New +$2.42M
IEMG icon
150
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
$2.47M 0.16%
43,423

Similar funds

Bailard's Q4 2017 Portfolio in Review

As of Q4 2017, Bailard held 457 positions worth $1.59B, up 23% from $1.29B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bailard deployed $232M of net new capital in Q4 2017, opening 156 new positions and adding to 101 existing holdings. Its largest new stake was Lam Research: 237,900 shares worth $4.38M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $59.1M trimmed.

  • Bailard's largest Q4 2017 buy was Lam Research: 237,900 shares worth $4.38M.
  • Bailard added most to Invesco QQQ Trust in Q4 2017, an estimated $53.1M increase.
  • Bailard's biggest Q4 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $59.1M.
  • Bailard fully exited Johnson Controls International in Q4 2017, selling an estimated $3.66M.
  • Bailard's ten largest holdings make up 33% of its $1.59B portfolio in Q4 2017.
  • Bailard opened 156 new positions and closed 28 in Q4 2017.
  • Bailard's portfolio value rose 23% quarter-over-quarter to $1.59B.

Based on Bailard's 13F filing for Q4 2017, filed 8 Feb 2018.